Clinical Trials Directory

Trials / Terminated

TerminatedNCT00250081

Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy

Multi Center Project: Comparison of Functional Outcomes of Tendon Transfer Surgery, Botulinum Toxin Injections and Regular Ongoing Treatment in Hemiplegic Upper Extremity Cerebral Palsy

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Shriners Hospitals for Children · Academic / Other
Sex
All
Age
4 Years – 17 Years
Healthy volunteers
Not accepted

Summary

Doctors use different treatments for people with Cerebral Palsy. Surgery is one option. Botulinum toxin injections are another option; these are given directly into spastic muscles to weaken them temporarily. Regular ongoing treatment (splinting, stretching and exercises) is another option. The investigators want to find out if surgery works better than Botulinum Toxin (Botox) injections or regular ongoing treatment (therapy), and if the effects of Botulinum Toxin injections last for longer than six months.

Detailed description

The specific aims of this study and the methodology for achieving them are: 1. To determine if tendon surgery for the forearm, wrist and thumb deformities of UECP is more effective than Botulinum toxin injections or regular ongoing treatment at improving function and quality of life for children with UECP. Children who are candidates for tendon surgery will be prospectively randomized to one of three treatment groups: standard tendon surgery, a series of three Botulinum toxin injections over a period of 12 months, and regular ongoing treatment. Validated tests of cognition, function and quality of life with tests of stereognosis and range of motion will be administered before, during and after treatment in order to compare outcomes of the three treatment groups. 2. To determine if serial Botulinum toxin injections have long-term beneficial effects on upper extremity function which outlast their paralytic effects. Botulinum toxin has been shown to have beneficial effects on UE function while the muscles injected remain weakened by the toxin. Clinicians have theorized that improvements in UE function are maintained after the toxin wears off, but this has not been proven. Children randomized to the Botulinum toxin injection group will receive 3 injections. Their function will be tested before the first injection, while the paralytic results of the second injection are still in effect, and after the paralytic effects of the third injection have worn off, and the results compared in order to determine if functional improvements outlast the medicinal effects.

Conditions

Interventions

TypeNameDescription
PROCEDUREUpper Extremity Tendon transfer
PROCEDUREBotulinum Toxin injections in Upper Extremity
PROCEDURERegularly ongoing therapy

Timeline

Start date
2005-02-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2005-11-07
Last updated
2014-11-19

Locations

10 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00250081. Inclusion in this directory is not an endorsement.